Concerning the clinical parameters, we found no significant differences between the HDR and LDR MN radiosensitive and non-sensitive patient group in age (unpaired t-test), tumour stage and grade, oestrogen/progesteron receptor positive status, and previous radio- or chemotherapy (chi-square test) of the patients. This evidence concerns the gene PGR and neoplasm.